Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST

Analytical Biochemistry

Volumn 375, Issue 1, 2008, Pages 144-146

  Kurihara, Takashi ^a   Yanagida, Atsushi ^a   Yokoi, Hiroyuki ^a   Koyata, Atsushi ^a   Matsuya, Takeshi ^a   Ogawa, Junichi ^a   Okamura, Yoshikazu ^a   Miyamoto, Daishi ^a  

^a MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CARDIOLOGY; CHEMILUMINESCENCE; ENZYMES; SENSITIVITY ANALYSIS;

ANALYTICAL PERFORMANCE; BRAIN NATRIURETIC PEPTIDE; CHEMILUMINESCENT ENZYME IMMUNOASSAYS; CLINICAL BIOCHEMISTRY; COEFFICIENTS OF VARIATIONS; CORRELATION COEFFICIENT; CREATINE KINASE; NATIONAL ACADEMIES;

IMMUNOLOGY;

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I;

ACCURACY; ANALYTIC METHOD; ANALYZER; ARTICLE; CHEMOLUMINESCENCE; ENZYME IMMUNOASSAY; EVALUATION; FALSE NEGATIVE RESULT; HEART; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 39749134203     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.12.030     Document Type: Article

References (11)

1. G.J. Kost N.K. Tran Point-of-care testing and cardiac biomarkers: The standard of care and vision for chest pain centers Cardiology 23 2005 467 490
2. M. Plebani M. Zaninotto Cardiac markers: Centralized or decentralized testing? Clin. Chem. Lab. Med. 37 1999 1113 1117
3. Joint European Society of Cardiology/American College of Cardiology Committee, Myocardial infarction redefined: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J. Am. Coll. Cardiol. 36 (2000) 959–969.
4. National Academy of Clinical Biochemistry, National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes, Clin. Chem. 53 (2007) 552–574.
5. M. Panteghini F. Pagani K.T.J. Yeo F.S. Apple R.H. Christenson F. Dati J. Mair J. Ravkilde A.H.B. Wu Evaluation of imprecision for cardiac troponin assays at low-range concentrations Clin. Chem. 50 2004 327 332
6. F.S. Apple M.M. Murakami Serum and plasma cardiac troponin I 99th percentile reference values for 32nd-generation assay Clin. Chem. 53 2007 1558 1560
7. K. Obata O. Segawa M. Yakabe Y. Ishida T. Kuroita K. Ikeda B. Kawakami Y. Kawamura M. Yohda T. Matsunaga H. Tajima Development of a novel method of operating magnetic particles, Magtration technology, and its use for automating nucleic acid purification J. Biosci. Bioeng. 91 2001 500 503
8. National Committee for Clinical Laboratory Standards, Evaluation of Precision Performance of Quantitative Measurement Methods: Approved Guideline–Second Edition, NCCLS document EP5-A2, 2004. (NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087, USA).
9. National Committee for Clinical Laboratory Standards, Protocols for Determination of Limits of Detection and Limits of Quantitation: Approved Guideline, NCCLS document EP17-A, 2004. (NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087, USA).
10. H. Passing W. Bablok A new biometrical procedure for testing the equality of measurements from two different analytical methods: Application of linear regression procedures for method comparison studies in clinical chemistry (part I) J. Clin. Chem. Clin. Biochem. 21 1983 709 720
11. H. Passing W. Bablok Comparison of several regression procedures for method comparison studies and determination of sample sizes: Application of linear regression procedures for method comparison studies in clinical chemistry (part II) J. Clin. Chem. Clin. Biochem. 22 1984 431 445